Kazuharu Tsuboi
Director/Board Member at 3-D Matrix Asia Pte. Ltd.
Network origin in Kazuharu Tsuboi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
3-D Matrix Asia Pte. Ltd.
2
| Subsidiary | 2 | |
Beijing 3-D Matrix Investment Consulting, Ltd.
1
| Private Company | 1 | |
| Public Company | Medical Specialties | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kazuharu Tsuboi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
3-D Matrix Da America Latina Representacão Comercial Ltda.
 3-D Matrix Da America Latina Representacão Comercial Ltda. Pharmaceuticals: MajorHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Da America Latina Representacão Comercial Ltda. is a medical product company based in São Paulo, Brazil. The Brazilian company engages in the research and development, manufacture, and sale of medical products. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
3-D Matrix Europe SAS
 3-D Matrix Europe SAS Medical SpecialtiesHealth Technology Part of 3-D Matrix Ltd., 3-D Matrix Europe SAS is a medical device company based in Lyon, France. The French company specializes in bleeding management in healthcare procedures using self-assembling peptide technology. The company's products, Purabond and Purastat, provide surgeons with a ready-to-use haemostatic agent in cardiac surgery and endoscopy. The company works with a team of suppliers and distributors to ensure their products reach hospitals. 3-D Matrix is a spin-off from MIT and has grown to become a leading peptide solutions company. | Medical Specialties | Director/Board Member Director/Board Member | |
| 3-D Matrix, Inc. | Director/Board Member Director/Board Member | ||
| Tokyo Medical University | College/University | Doctorate Degree | |
Ai-BrainScience, Inc.
 Ai-BrainScience, Inc. Financial ConglomeratesFinance Ai-BrainScience, Inc. is a company founded in 2019 and based in Osaka, Japan. The Japanese company specializes in developing medical devices using the "aitracking type cognitive function evaluation method" to find early detection of dementia and achieve early intervention. The company's website provides a technical introduction to their cognitive function evaluation method and their business investment opportunities. | Financial Conglomerates | President | |
| INSEAD | College/University | Masters Business Admin | |
| University of Tokyo Faculty of Law & Graduate Schools for Law | College/University | Graduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
| School of Engineering, The University of Tokyo | College/University | Undergraduate Degree |
Statistics
International
| Japan | 4 |
| United States | 3 |
| France | 3 |
| Brazil | 2 |
Sectoral
| Consumer Services | 6 |
| Health Technology | 3 |
| Finance | 2 |
Operational
| Director/Board Member | 12 |
| President | 3 |
| Masters Business Admin | 2 |
| Doctorate Degree | 1 |
| Chief Administrative Officer | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Jun Okada | 8 |
| Keiji Nagano | 7 |
| Kentaro Takamura | 3 |
- Stock Market
- Insiders
- Kazuharu Tsuboi
- Company connections
